News Aprazer Healthcare Launched OCABEST September 29, 2021 Posted by Aprazer 10 Aug 2020 Launch Date: 10/08/20 Aprazer Healthcare Launched OCABEST (Obeticholic Acid ) which is a medication indicated for the treatment of Primary Biliary Cirrhosis who have not responded to UDCA treatment.